Equillium, Inc. Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ANEB
|
Anebulo Pharmaceuticals, Inc. | $1.53 | $56.28 M | -5.86 | 2 | $0 |
 ANTX
|
AN2 Therapeutics, Inc. | $1.00 | $60.55 M | -0.81 | 41 | $0 |
 BCAB
|
BioAtla, Inc. | $1.51 | $73.14 M | -0.61 | 65 | $0 |
 BOLT
|
Bolt Biotherapeutics, Inc. | $0.57 | $29.02 M | -0.46 | 100 | $7.88 M |
 CHRS
|
Coherus BioSciences, Inc. | $0.78 | $193.89 M | -2.28 | 235 | $257.24 M |
 CINGW
|
Cingulate Inc. | $0.04 | $4.47 M | -0.01 | 13 | $0 |
 CUE
|
Cue Biopharma, Inc. | $1.09 | $71.99 M | -1.38 | 53 | $5.49 M |
 CVKD
|
Cadrenal Therapeutics, Inc. Common Stock | $15.82 | $7.53 M | 0 | 4 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $30.77 | $1.65 B | -11.47 | 108 | $0 |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 HOOK
|
HOOKIPA Pharma Inc. | $2.79 | $79.07 M | -1.71 | 151 | $20.13 M |
 HOWL
|
Werewolf Therapeutics, Inc. | $1.71 | $151.66 M | -3.17 | 45 | $19.94 M |
 IKNA
|
Ikena Oncology, Inc. | $1.67 | $84.45 M | -1.11 | 14 | $9.16 M |
 JSPR
|
Jasper Therapeutics, Inc. | $20.06 | $369.90 M | -0.4 | 45 | $0 |
 KTTA
|
Pasithea Therapeutics Corp. | $3.20 | $5.84 M | -0.41 | 8 | $0 |
 LIAN
|
LianBio | $0.32 | $34.47 M | -0.39 | 163 | $0 |
 LIFE
|
aTyr Pharma, Inc. | $1.90 | $131.12 M | -2.16 | 56 | $353,000 |
 LYRA
|
Lyra Therapeutics, Inc. | $0.16 | $19.53 M | -0.27 | 88 | $1.56 M |
 MNPR
|
Monopar Therapeutics Inc. | $18.69 | $14.18 M | -1.56 | 9 | $0 |
 NLTX
|
Neoleukin Therapeutics, Inc. | $3.49 | $8.20 M | -0.28 | 7 | $0 |
 QNRX
|
Quoin Pharmaceuticals, Ltd. | $0.61 | $2.73 M | -0.11 | 4 | $0 |
 SABS
|
SAB Biotherapeutics, Inc. | $3.20 | $27.17 M | -0.44 | 57 | $2.24 M |
 SPRO
|
Spero Therapeutics, Inc. | $1.14 | $75.85 M | 3.19 | 46 | $96.74 M |
 TRVI
|
Trevi Therapeutics, Inc. | $2.82 | $171.86 M | -7.18 | 27 | $0 |